Follow The Filings

KIDS OrthoPediatrics

OrthoPediatrics earnings company data as of 7:58 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 27 Oct EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by KIDS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KIDS insider trades
  • None no insider bought on the open market
  • $46.7M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Squadron Capital LLC 10% owner, +1 joint filer
    Sale
    $6.4M 302,369 shares at $21.01 4.6% of stake
    Traded Sep 10 Filed Sep 11
    ↗
  2. David R Pelizzon Director
    Sale
    $525K 22,500 shares at $23.35 0.3% of stake
    Traded Sep 2 Filed Sep 4
    ↗
  3. David R Pelizzon Director
    Sale
    $7.8M 336,831 shares at $23.04 4.9% of stake
    Traded Aug 28–Sep 1 Filed Sep 1
    ↗
  4. David R Pelizzon Director
    Sale
    $943K 38,300 shares at $24.63 0.6% of stake
    Traded Aug 24–26 Filed Aug 26
    ↗

Also filed in the last 12 months, not counted as buying or selling: 15 stock grants, 5 sales to cover taxes, and 2 gifts.

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 1.01,2.03,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.